BioCryst Pharmaceuticals, Inc. financials

   Watch this stock
In Millions of USD (except for per share items) 3 months ending 2015-03-31 3 months ending 2014-12-31 3 months ending 2014-09-30 3 months ending 2014-06-30 3 months ending 2014-03-31
Revenue 6.83 5.45 3.24 1.47 3.46
Other Revenue, Total - - - - -
Total Revenue 6.83 5.45 3.24 1.47 3.46
Cost of Revenue, Total 0.01 0.00 - - -
Gross Profit 6.81 5.45 - - -
Selling/General/Admin. Expenses, Total 4.06 2.05 1.81 2.01 1.59
Research & Development 17.12 18.51 13.04 11.07 9.18
Depreciation/Amortization - - - - -
Interest Expense(Income) - Net Operating - - - - -
Unusual Expense (Income) - 0.00 - - -
Other Operating Expenses, Total 0.06 0.04 0.00 0.01 0.07
Total Operating Expense 21.26 20.60 14.85 13.09 10.84
Operating Income -14.43 -15.16 -11.61 -11.62 -7.39
Interest Income(Expense), Net Non-Operating - - - - -
Gain (Loss) on Sale of Assets - - - - -
Other, Net - - - - -
Income Before Tax -15.16 -11.67 -8.73 -14.65 -10.14
Income After Tax -15.16 -11.67 -8.73 -14.65 -10.14
Minority Interest - - - - -
Equity In Affiliates - - - - -
Net Income Before Extra. Items -15.16 -11.67 -8.73 -14.65 -10.14
Accounting Change - - - - -
Discontinued Operations - - - - -
Extraordinary Item - - - - -
Net Income -15.16 -11.67 -8.73 -14.65 -10.14
Preferred Dividends - - - - -
Income Available to Common Excl. Extra Items -15.16 -11.67 -8.73 -14.65 -10.14
Income Available to Common Incl. Extra Items -15.16 -11.67 -8.73 -14.65 -10.14
Basic Weighted Average Shares - - - - -
Basic EPS Excluding Extraordinary Items - - - - -
Basic EPS Including Extraordinary Items - - - - -
Dilution Adjustment - - - - 0.00
Diluted Weighted Average Shares 72.34 71.92 71.80 63.65 59.59
Diluted EPS Excluding Extraordinary Items -0.21 -0.16 -0.12 -0.23 -0.17
Diluted EPS Including Extraordinary Items - - - - -
Dividends per Share - Common Stock Primary Issue 0.00 0.00 0.00 0.00 0.00
Gross Dividends - Common Stock - - - - -
Net Income after Stock Based Comp. Expense - - - - -
Basic EPS after Stock Based Comp. Expense - - - - -
Diluted EPS after Stock Based Comp. Expense - - - - -
Depreciation, Supplemental - - - - -
Total Special Items - - - - -
Normalized Income Before Taxes - - - - -
Effect of Special Items on Income Taxes - - - - -
Income Taxes Ex. Impact of Special Items - - - - -
Normalized Income After Taxes - - - - -
Normalized Income Avail to Common - - - - -
Basic Normalized EPS - - - - -
Diluted Normalized EPS -0.21 -0.16 -0.12 -0.23 -0.17